{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:10:44Z","timestamp":1781788244420,"version":"3.54.5"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic <jats:italic>Leishmania<\/jats:italic> parasites to impart Sb resistance. In a limited number of clinical isolates (<jats:italic>n<\/jats:italic> = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). One of the isolates, T5, that was genotypically characterized as\u00a0<jats:italic>Leishmania tropica<\/jats:italic>, caused Indian Kala-azar and was phenotypically Sb resistant (T5-LT-SSG-R), while the other two were\u00a0<jats:italic>Leishmania donovani<\/jats:italic>, out of which one\u00a0isolate, AG83, is antimony sensitive (AG83-LD-SSG-S) and the other isolate, T8, is Sb resistant (T8-LD-SSG-R).\u00a0Our study showed that the Sb-resistant parasites, regardless of their genotype, showed significantly higher intracellular thiol compared with Sb-sensitive AG83-LD-SSG-S. Seemingly, T5-LT-SSG-R showed about 1.9-fold higher thiol content compared with T8-LD-SSG-R which essentially mirrored cell surface N-acetyl-D-galactosaminyl expression. Except TR, the expression of the remaining thiol-synthesizing genes was significantly higher in T8-LD-SSG-R and T5-LT-SSG-R than the sensitive one, and between the Sb-resistant parasites, the latter showed a significantly higher expression. Furthermore, the genes for Sb-reducing enzymes increased significantly in resistant parasites regardless of genotype compared with the sensitive one, and between two resistant parasites, there was hardly any difference in expression. Out of three antimony transporters, AQP1 was decreased with the concurrent increase in MRPA and PRP1 in resistant isolates when compared with the sensitive counterpart. Interestingly, no difference in expression of the above-mentioned transporters was noted between two Sb-resistant isolates. The enduring image that resonated from our study is that the genetically diverse Sb-resistant parasites showed enhanced thiol-synthesizing and antimony transporter gene expression than the sensitive counterpart to confer a resistant phenotype.<\/jats:p>","DOI":"10.3389\/fcimb.2022.1021464","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T10:06:01Z","timestamp":1667383561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Supriya","family":"Khanra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanabha","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nibedeeta Rani","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","article-title":"Molecular mechanisms of antimony resistance in leishmania","volume":"56","author":"Ashutosh","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.638957","article-title":"Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: A focus on anthroponotic form due to leishmania tropica","volume":"12","author":"Bamorovat","year":"2021","journal-title":"Front. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1128\/IAI.00057-09","article-title":"Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells","volume":"77","author":"Banerjee","year":"2009","journal-title":"Infect. Immun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","article-title":"Effects of antimycotic azoles on growth and sterol biosynthesis of leishmania promastigotes","volume":"31","author":"Beach","year":"1988","journal-title":"Mol. Biochem. Parasitol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2307\/3280147","article-title":"Lipids of leishmania promastigotes","volume":"65","author":"Beach","year":"1979","journal-title":"J. Parasitol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"626838","DOI":"10.1155\/2012\/626838","article-title":"Developments in diagnosis and antileishmanial drugs","volume":"2012","author":"Bhargava","year":"2012","journal-title":"Inter. Discip. Perspect. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci. 15"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1128\/AAC.00404-07","article-title":"Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in leishmania amastigotes","volume":"51","author":"Coelho","year":"2007","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.49.11.4616-4621.2005","article-title":"Gene expression analysis of the mechanism of natural Sb(V) resistance in leishmania donovani isolates from Nepal","volume":"49","author":"Decuypere","year":"2005","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001514","article-title":"Molecular mechanisms of drug resistance in natural leishmania populations vary with genetic background","volume":"6","author":"Decuypere","year":"2012","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20040283","article-title":"Reduction of antileishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1","volume":"15","author":"Denton","year":"2004","journal-title":"Biochem. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","article-title":"Role of the ABC transporter MRPA (PGPA) in antimony resistance in leishmania infantum axenic and intracellular amastigotes","volume":"49","author":"El Fadili","year":"2005","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1365-2249.2000.01163.x","article-title":"The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of leishmania reactivity by peripheral blood mononuclear cells (PBMC)","volume":"119","author":"Gasim","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0166-6851(84)90004-5","article-title":"Sterols of leishmania species. implications for biosynthesis","volume":"10","author":"Goad","year":"1984","journal-title":"Mol. Biochem. Parasitol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/emboj\/16.11.3057","article-title":"Coamplification of the gamma-glutamylcysteine synthetase gene gsh1 and of theABC transporter gene pgpA in arsenite-resistant leishmania tarentolae","volume":"16","author":"Grondin","year":"1997","journal-title":"EMBO. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1046\/j.1365-2958.1999.01634.x","article-title":"Elevated levels of polyamines and trypanothione resultingfrom overexpression of the ornithine decarboxylase gene in arsenite resistant leishmania","volume":"34","author":"Haimeur","year":"1999","journal-title":"Mol. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"571242","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"B20","volume-title":"Analysis of the genome and genetic markers of the clinical isolates of Indian kala-azar for molecular taxonomical purpose","author":"Khanra","year":"2015"},{"key":"B21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.actatropica.2012.08.017","article-title":"RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of kala-azar from India and Bangladesh confirms the association of l. tropica with the disease","volume":"124","author":"Khanra","year":"2012","journal-title":"Acta Trop."},{"key":"B22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.actatropica.2016.09.012","article-title":"Genetic markers for antimony resistant clinical isolates differentiation from Indian kala-azar","volume":"164","author":"Khanra","year":"2016","journal-title":"Acta Trop."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.1038\/s41598-017-09720-1","article-title":"Miltefosine resistant field isolate from Indian kala-azar patient shows similar phenotype in experimental infection","volume":"7","author":"Khanra","year":"2017","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of leishmania donovani to miltefosine and amphotericin b: Correlation withsodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"Kumar","year":"2009","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1017\/S0031182007003150","article-title":"Increased levels of thiols protect antimony unresponsive leishmania donovani field isolate against reactive oxygen species generated by trivalent antimony","volume":"134","author":"Mandal","year":"2007","journal-title":"Parasitology"},{"key":"B26","first-page":"BR220","article-title":"The molecular characterization of clinical isolatesfrom Indian kala-azar patients by MLEE and RAPD-PCR","volume":"11","author":"Manna","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s13071-018-2953-y","article-title":"Leishmaniasis and glycosaminoglycans: a future therapeutic strategy","volume":"11","author":"Merida-de-Barros","year":"2018","journal-title":"Parasit. Vectors."},{"key":"B28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","article-title":"Characterization of natural antimony resistance in leishmania donovani isolates","volume":"76","author":"Mittal","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"239208","DOI":"10.1155\/2014\/239208","article-title":"A lectin from dioclea violacea interacts with midgut surface of lutzomyia migonei, unlike its homologues, cratylia floribunda lectin and canavalia gladiata lectin","volume":"2014","author":"Monteiro T\u00ednel","year":"2014","journal-title":"Sci. World J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001987","article-title":"Imipramine is an orally active drug against both antimony sensitive and resistant leishmania donovani clinical isolates in experimental infection","volume":"6","author":"Mukherjee","year":"2012","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E575","DOI":"10.1073\/pnas.1213839110","article-title":"Antimony-resistant but not antimony-sensitive leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1","volume":"110","author":"Mukherjee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jac\/dkl494","article-title":"Role ofABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithinedecarboxylase in natural antimony-resistant isolates of leishmania donovani","volume":"59","author":"Mukherjee","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ijpara.2011.07.013","article-title":"Characterization of antimony-resistant leishmania donovani isolates: Biochemical and biophysical studies and interaction with host cells","volume":"41","author":"Mukhopadhyay","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1074\/jbc.M009774200","article-title":"Characterization of transsulfuration and cysteine biosynthetic pathways inthe protozoan hemoflagellate, trypanosoma cruzi. isolation and molecularcharacterization of cystathionine beta-synthase and serine acetyltransferasefrom trypanosoma","volume":"276","author":"Nozaki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling","volume":"23","author":"Oliaee","year":"2018","journal-title":"Trop. Med. Int. Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/tmi.12092","article-title":"Retrospective quarterly cohort monitoring for patientswith visceral leishmaniasis in the Indian subcontinents: outcomes of apilot project","volume":"18","author":"Ostyn","year":"2013","journal-title":"Trop. Med. Int. Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1128\/AAC.00700-11","article-title":"Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis","volume":"56","author":"Palit","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PloS Negl. Trop. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin b resistance in clinical isolates of leishmania donovani","volume":"56","author":"Purkait","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans. R. Soc Trop. Med. Hyg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0140-6736(95)90703-3","article-title":"Indian Kala-azar caused by leishmania tropica","volume":"345","author":"Sacks","year":"1995","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.exppara.2009.04.012","article-title":"Flow cytometric determination of intracellular non-protein thiols in leishmania promastigotes using 5-chloromethyl fluorescein diacetate","volume":"122","author":"Sarkar","year":"2009","journal-title":"Exp. Parasitol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"106086","DOI":"10.1016\/j.actatropica.2021.106086","article-title":"Genome wide comparison of leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients","volume":"223","author":"Sarraf","year":"2021","journal-title":"Acta Trop."},{"key":"B45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13071-014-0596-1","article-title":"The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (Kala-azar) in India","volume":"7","author":"Singh","year":"2014","journal-title":"Parasitol. Vectors"},{"key":"B46","doi-asserted-by":"publisher","first-page":"239469","DOI":"10.1155\/2015\/239469","article-title":"Developments in diagnosis of visceral leishmaniasis in the elimination era","volume":"2015","author":"Singh","year":"2015","journal-title":"J. Parasitol. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"B48","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012211","article-title":"Linking in vitro and in vivo survival of clinical leishmania donovani strains","volume":"5","author":"Vanaerschot","year":"2010","journal-title":"PloS One"},{"key":"B51","unstructured":"Antimicrobial resistance2021"},{"key":"B52","unstructured":"Leishmaniasis2022"},{"key":"B53","doi-asserted-by":"publisher","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugson thiol redox metabolism in the human pathogen leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1021464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T10:06:08Z","timestamp":1667383568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1021464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":53,"alternative-id":["10.3389\/fcimb.2022.1021464"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1021464","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"1021464"}}